In this study, we show that this novel combination therapy using Honokiol effectively promotes the apoptosis of renal cancer cells, possibly through the inhibition cytoprotective HO-1 and up-regulation of cellular ROS. The gene discussed is HMOX1; the disease is renal carcinoma.